TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages

Journal of Immunology

Volumn 164, Issue 6, 2000, Pages 2897-2904

  Kaplan, Mariana J ^a   Ray, Donna ^a   Mo, Ru Ran ^a   Yung, Raymond L ^a   Richardson, Bruce C ^a,b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Geriatrics Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN 2; APOLIPOPROTEIN 3; CD4 ANTIGEN; FAS ANTIGEN; FAS LIGAND; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; GENE EXPRESSION REGULATION; IMMUNOREGULATION; LIGAND BINDING; MACROPHAGE ACTIVATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION;

EID: 0034653391     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.6.2897     Document Type: Article

References (45)

1. Meuret, G., J. Bammert, and G. Hoffmann. 1974. Kinetics of human monocytopoiesis. Blood 44:801.
2. Meuret, G., and G. Hoffmann. 1973. Monocyte kinetic studies in normal and disease states. Br. J. Haematol. 24:275.
3. Pistoia, V. 1991. Granulocyte-macrophage colony stimulating factor (GM-CSF): sources, targets and mechanism of action. Leukemia 5(Suppl. 1):114.
4. Bajorin, D. F., N. K. Cheung, and A. N. Houghton. 1991. Macrophage colony-stimulating factor: biological effects and potential applications for cancer therapy. Semin. Hematol. 28(Suppl. 2):42.
5. Mangan, D. F., B. Robertson, and S. M. Wahl. 1992. IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J. Immunol. 148:1812.
6. Mangan, D. F., and S. M. Wahl. 1991. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J. Immunol. 147:3408.
7. Mangan, D. F., G. R. Welch, and S. M. Wahl. 1991. Lipopolysaccharide, tumor necrosis factor-α, and IL-1β prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J. Immunol. 146:1541.
8. + T cells. Eur. J. Immunol. 23:1450.
9. + T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to induce a lupus-like disease in syngeneic mice. J. Clin. Invest. 92:38.
10. Yung, R. L., J. Quddus, C. E. Chrisp, K. J. Johnson, and B. C. Richardson. 1995. Mechanisms of drug induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J. Immunol. 154: 3025.
11. Richardson, B. C., R. L. Yung, P. Rowse, K. J. Johnson, and N. D. Lalwani. 1996. Monocyte apoptosis in patients with active lupus. Arthritis Rheum. 39:1432.
12. Richardson, B. C., J. R. Strahler, T. S. Pivirotto, J. Quddus, G. E. Bayliss, L. A. Gross, K. S. O'Rourke, D. J. Powers, S. M. Hanash, and M. A. Johnson. 1992. Phenotypic and functional similarities between 5-azacytidine treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum. 35:647.
13. + T cell clones use perforin-or Fas/Fas ligand mediated pathways for target cell lysis. J. Immunol. 158:2756.
14. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
15. Richardson, B. C., N. D. Lalwani, K. J. Johnson, and R. M. Marks. 1994. Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur. J. Immunol. 24:2640.
16. + lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway. Proc. Natl. Acad. Sci. USA 92:11225.
17. Yung, R., D. Powers, K. Johnson, E. Amento, D. Carr, T. Laing, J. Yang, S. Chang, N. Hemati, and B. Richardson. 1996. Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupus-like disease in syngeneic recipients. J. Clin. Invest. 97:2866.
18. Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, and S. Nagata. 1994. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154:3806.
19. Lancki, D. W., C.-S. Hsieh, and F. W. Fitch. 1991. Mechanisms of lysis by cytotoxic T lymphocyte clones. J. Immunol. 146:3242.
20. Saizawa, M. K., E. Hug, S. Haque, P. Portoles, S. Suzuki, and K. Eichmann. 1992. Autoreactivity of low but not of high CD4 variants of an antigen-specific. I-A-restricted mouse T cell clone. J. Immunol. 148:702.
21. Ashwell, J. D., G. S. Fox, and R. H. Schwartz. 1986. Functional analysis of the interaction of the antigen-specific T cell receptor with its ligands. J. Immunol. 136:757.
22. Yang, J., C. Deng, N. Hemati, S. M. Hanash, and B. C. Richardson. 1997. Effect of mitogenic stimulation and DNA methylation on human T-cell DNA methyl-transferase expression and activity. J. Immunol. 159:1303.
23. Deng, C., J. Yang, J. Scott, S. Hanash, and B. Richardson. 1998. Role of the Ras-MAPK signaling pathway in the DNA methyltransferase response to DNA hypomethylation. J. Biol. Chem. 379:1113.
24. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
25. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37:269.
26. + T lymphocytes. J. Immunol. 152:1523.
27. Wiley, S. R., K. Schooley, P. J. Smolak, W. S. Din, C. P. Huang, J. K. Nicholl, G. R. Sutherland, T. Davis Smith, C. Rauch, C. A. Smith, and R. G. Goodwin. 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673.
28. Pitti, R. M., S. A. Marsters, S. Ruppert, C. J. Donahue, A. Moore, and A. Ashkenazi. 1996. Induction of apoplosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271:12687.
29. Mariani, S. M., and P. H. Krammer. 1998. Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells. Eur. J. Immunol. 28:1492.
30. Pan, G., K. O'Rourke, A. M. Chinnaiyan, R. Gentz, R. Ebner, J. Ni, and V. M. Dixit. 1997. The receptor for the cytotoxic ligand TRAIL. Science 276: 111.
31. Griffith, T. S., and D. H. Lynch. 1998. TRAIL: a molecule with multiple receptors and control mechanisms. Curr. Opin. Immunol. 10:559.
32. Chicheportiche, Y., P. R. Bourdon, H. Xu, Y. M. Hsu, H. Scott, C. Hession, I. Garcia, and J. L. Browning. 1997. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272:32401.
33. Marsters, S. A., J. P. Sheridan, R. M. Pitti, J. Brush, A. Goddard, and A. Ashkenazi. 1998. Identification of a ligand for the death-domain-containing receptor Apo-3. Curr. Biol. 8:525.
34. Braun, M. Y., B. Lowin, L. French, H. Acha-Orbea, and J. Tschopp. 1996. Cytotoxic T cells deficient in both functional Fas ligand and perform show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med. 183:657.
35. Shresta, S., C. T. Pham, D. A. Thomas, T. A. Graubert, T. J. Ley. 1998. How do cytotoxic lymphocytes kill their targets? Curr. Opin. Immunol. 10:581.
36. Hernandez-Caselles, T., and O. Stutman. 1993. Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6 induced proliferation depending on the concentration of mitogenic costimulation. J. Immunol. 151:3999.
37. Ashkenazi, A., and V. M. Dixit. 1998. Death receptors: signaling and modulation. Science 281:1305.
38. Sheridan, J. P., S. A. Marsters, R. M. Pitti, A. Gurney, M. Skubatch, D. Baldwin, L. Ramakrishnan, C. L. Gray, K. Baker, W. I. Wood, et al. 1997. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277:818.
39. Martinez-Lorenzo, M. J., M. A. Alava, S. Garmen, K. J. Kim, A. Chuntharapai, A. Pineiro, J. Naval, and A. Anel. 1998. Involvement of Apo2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur. J. Immunol. 28:2714.
40. Bodmer, J. L., K. Burns, P. Schneider, K. Hofmann, V. Steiner, M. Thome, T. Bornand, M. Hahne, M. Schroter, K. Becker, et al. 1997. TRAMP, a novel apoptosis -mediating receptor with sequence homology to tumor necrosis factor receptor I and Fas (Apo-I/CD95). Immunity 6:79.
41. Marsters, S., J. Sheridan, C. Donahue, R. Pitti, R. Gray, A. Goddard, and A. Ashkenazi. 1996. Apo3, a new member of the tumor necrosis factor receptor family, contains a death-domain and activates apoptosis and NF-κB. Curr. Biol. 6:1669.
42. Chinnaiyan, A. M., K. O'Rourke, G. L. Yu, R. H. Lyons, M. Garg, D. R. Duan, L. Xing, R. Gentz, J. Ni, and V. M. Dixit. 1996. Signal transduction by DR3, a death-domain-containing receptor related to TNFR-1 and CD95. Science 274:990.
43. Kitson, J., T. Raven, Y. P. Jiang, D.V. Goeddel, K. M. Giles, and K. T. Pun et al. 1996. A death-domain-containing receptor that mediates apoptosis. Nature 384: 372.
44. Screaton, G., X. Xu, A. Olsen, A. Cowper, R. Tan, A. McMichael and J. Bell. 1997. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 94:4615.
45. Spielman, J., R. K. Lee, and E. R. Podack. 1998. Perforin/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis. J. Immunol. 161:7063.